Research Article
A Chemiluminescent Immunoassay for Osteocalcin in Human Serum and a Solution to the “Hook Effect”
Table 6
Distribution of clinical samples.
| Populations | Conc. of BGP (ng/mL) | Fracture | Osteoporosis | Autoimmune diseases | Cancer | Diabetes | Cardiovascular disease |
| Postmenopausal female | <10 | 7 | 6 | 43 | 34 | 40 | 2 | 10∼30 | 21 | 24 | 117 | 65 | 194 | 17 | >30 | 1 | 3 | 8 | 28 | 13 | 2 |
| Male | <10 | 1 | 2 | 7 | 43 | 66 | 11 | 10∼40 | 6 | 2 | 26 | 58 | 141 | 56 | >40 | 1 | 0 | 1 | 14 | 1 | 8 |
|
|